Hudson Bay Capital Management LP Vertex Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

A detailed history of Hudson Bay Capital Management LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 30,000 shares of VRTX stock, worth $13.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

30,000

Previous 137,500 78.18%

Holding current value

$13.5 Million

Previous $64.4 Million 78.35%

% of portfolio

0.06%

Previous 0.35%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$460.0 - $505.78 $49.5 Million - $54.4 Million	-107,500 Reduced 78.18%	30,000 $14 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $54 Million - $66.8 Million	137,500 New	137,500 $64.4 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $10.3 Million - $12.3 Million	30,000 Added 428.57%	37,000 $15.1 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $2.37 Million - $2.54 Million	7,000 New	7,000 $2.43 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $9.14 Million - $10.3 Million	32,000 New	32,000 $9.24 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $7.2 Million - $8.48 Million	-32,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $5.31 Million - $6.7 Million	-30,000 Reduced 48.0%	32,500 $7.14 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $1.36 Million - $1.52 Million	7,500 Added 13.64%	62,500 $11.3 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $412,478 - $486,420	2,200 Added 4.17%	55,000 $11.1 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $4.72 Million - $5.5 Million	22,800 Added 76.0%	52,800 $11.3 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $4.14 Million - $5.52 Million	20,000 Added 200.0%	30,000 $7.09 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $2.56 Million - $3.03 Million	10,000 New	10,000 $2.72 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $2.3 Million - $2.67 Million	-14,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $2.29 Million - $2.73 Million	14,000 New	14,000 $2.58 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $5.03 Million - $5.78 Million	-30,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$151.6 - $177.13 $3.03 Million - $3.54 Million	-20,000 Reduced 40.0%	30,000 $4.89 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $7.41 Million - $8.11 Million	50,000	50,000 $7.6 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Vertex Pharmaceuticals Inc Transaction History